Free Trial
OTCMKTS:NVZMF

Novozymes A/S (NVZMF) Stock Price, News & Analysis

$69.70
+2.45 (+3.64%)
(As of 09/16/2024 ET)
Today's Range
$69.70
$69.93
50-Day Range
$59.32
$71.40
52-Week Range
$38.85
$71.40
Volume
1,090 shs
Average Volume
1,444 shs
Market Capitalization
N/A
P/E Ratio
8.69
Dividend Yield
2.58%
Price Target
N/A
NVZMF stock logo

About Novozymes A/S Stock (OTCMKTS:NVZMF)

Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services. In addition, the company provides dishwashing, softener, microbial and medical cleaning services. Further, it provides corn, cotton, forages, peanuts, pulses, soybeans, wheat, small grains, bioyield, and biocontrol solutions; warm water species, recirculating aquaculture system; animal health and nutrition solutions; fiber modification, bleach boosting, deposit control, and starch modification solutions. Additionally, the company provides carbon capture, leather and textiles solutions; enzyme solutions, including corn and wheat separation, liquefaction, saccharification, filtration, isomerization, maltose, and specialties solutions; warm water species and recirculating aquaculture system solutions; human health solutions, comprising brain, oral, protective and immune, and gastrointestinal health solutions; ethanol, biodiesel, renewable diesel, education, wastewater, and sewage sludge, and renewable diesel solutions; agriculture and industry, biogas food waste, food waste, biocatalysis, cell culture, diagnostics, enzyme, and biogas solutions. Furthermore, it provides lipases, proteases, oxidoreductases, and carbohydrases. Novozymes A/S was founded in 1925 and is based in Bagsvaerd, Denmark.

NVZMF Stock Price History

NVZMF Stock News Headlines

Novozymes A/S (NVZMF) Q2 2024 Earnings Call Transcript
Novonesis A/S Series B
The #1 Altcoin for September 2024
With thousands of cryptocurrencies out there, it's crucial to focus on the ONE that has the potential to make HUGE gains. Now, I'm about to reveal the #1 crypto for September 2024.
Novozymes A/S (NZM2.BE)
Trading by management and close relations of management
Recap: Novozymes Q4 Earnings
Results update for 2023 – unaudited
The #1 Altcoin for September 2024
With thousands of cryptocurrencies out there, it's crucial to focus on the ONE that has the potential to make HUGE gains. Now, I'm about to reveal the #1 crypto for September 2024.
Legacy Novozymes delivers solid last full-year results
Novozymes A/S B (0Q4U)
Novozymes A/S Class B NVZMF
Not Just Yogurt Anymore
See More Headlines
Receive NVZMF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Novozymes A/S and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
4/20/2016
Today
9/16/2024

Industry, Sector and Symbol

Industry
Specialty Chemicals
Sub-Industry
N/A
Current Symbol
OTCMKTS:NVZMF
Fax
N/A
Employees
6,397
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

Key Executives

  • Ms. Ester Baiget (Age 53)
    President & CEO
    Comp: $2.77M
  • Mr. Rainer Lehmann (Age 49)
    Executive VP & CFO
    Comp: $747.1k
  • Mr. Anders Lund (Age 51)
    Chief Operating Officer
    Comp: $905.14k
  • Mr. Claus Crone Fuglsang (Age 56)
    Chief Scientific Officer
  • Mr. Tobias Cornelius Bjorklund
    Head of Investor Relations
  • Ms. Winnie Hoejvang Bugel (Age 59)
    General Counsel of Legal
  • Mr. Tue Micheelsen
    Vice President of Global Sales & Marketing
  • Mr. Morten Enggaard Rasmussen (Age 48)
    Executive Vice President of People & Stakeholder Relations
  • Ms. Tina Sejersgaard Fano (Age 55)
    Executive Vice President of Planetary Health Biosolutions
    Comp: $890.77k
  • Ms. Amy Byrick (Age 50)
    Executive Vice President of Human Health Biosolutions

NVZMF Stock Analysis - Frequently Asked Questions

How have NVZMF shares performed this year?

Novozymes A/S's stock was trading at $54.99 at the beginning of 2024. Since then, NVZMF stock has increased by 22.3% and is now trading at $67.25.
View the best growth stocks for 2024 here
.

How were Novozymes A/S's earnings last quarter?

Novozymes A/S (OTCMKTS:NVZMF) posted its earnings results on Wednesday, April, 20th. The biotechnology company reported $0.37 EPS for the quarter, missing the consensus estimate of $2.43 by $2.06.

How do I buy shares of Novozymes A/S?

Shares of NVZMF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:NVZMF) was last updated on 9/16/2024 by MarketBeat.com Staff

From Our Partners